| Members |
associationTargetComponent |
| pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) |
pN2 |
| pN2: Metastasis in more than one regional lymph node (kidney) |
pN2 |
| pN2: Metastasis in the subcarinal lymph node(s) and/or the ipsilateral internal mammary or mediastinal lymph node(s) (thoracic mesothelioma) |
pN2 |
| pN2: Metastasis in unilateral internal iliac AND/OR inguinal lymph node(s) (anal canal) |
pN2 |
| pN2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes(s) (lung) |
pN2 |
| pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension of tumour (testis) |
pN2 |
| pN2a category |
pN2a |
| pN2a: Clinically occult (microscopic) metastasis (melanoma of the skin) |
pN2a |
| pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) (breast) |
pN2a |
| pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension (upper aerodigestive tract) |
pN2a |
| pN2b category |
pN2b |
| pN2b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) |
pN2b |
| pN2b: Metastasis in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) |
pN2b |
| pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) |
pN2b |
| pN2c category |
pN2c |
| pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) |
pN2c |
| pN2c: Satellite or in-transit metastasis without nodal metastasis (melanoma of the skin) |
pN2c |
| pN3 category |
pN3 |
| pN3: Metastasis in a lymph node(s), more than 6 cm in dimension, and/or to supraclavicular fossa (nasopharynx) |
pN3 |
| pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) |
pN3 |
| pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension (upper aerodigestive tract) |
pN3 |
| pN3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s) (melanoma of the skin) |
pN3 |
| pN3: Metastasis in more than 15 regional (perigastric) lymph nodes (stomach) |
pN3 |
| pN3: Metastasis in perirectal and inguinal lymph nodes AND/OR bilateral internal iliac AND/OR inguinal lymph nodes (anal canal) |
pN3 |
| pN3: Metastasis in the contralateral mediastinal, internal mammary, or hilar lymph node(s), and/or the ipsilateral or contralateral supraclavicular or scalene lymph node(s) (thoracic mesothelioma) |
pN3 |
| pN3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s) (lung) |
pN3 |
| pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension (testis) |
pN3 |
| pN3a category |
pN3a |
| pN3a: Metastasis in 10 or more axillary lymph nodes (at least one tumour deposit greater than 2.0 mm), or metastasis to infraclavicular lymph nodes (breast) |
pN3a |
| pN3a: Metastasis in a lymph node(s), more than 6 cm in dimension (nasopharynx) |
pN3a |
| pN3b category |
pN3b |
| pN3b: Metastasis in lymph node(s) residing wholly or in part in the supraclavicular fossa (nasopharynx) |
pN3b |
| pN3b: Tumour of breast with metastasis as per AJCC 6th Edition definition (breast) |
pN3b |
| pN3c category |
pN3c |
| pN3c: Metastasis in ipsilateral supraclavicular lymph nodes (breast) |
pN3c |
| pNX category |
pNX |
| pNX: Regional lymph nodes cannot be assessed (e.g., previously removed, or not removed for pathologic study) (breast) |
pNX |
| pT category finding |
American Joint Committee on Cancer pathological T category allowable value |
| pT category not identified |
pTX |
| pT0 category |
pT0 |
| pT0: No evidence of primary tumour (breast) |
pT0 |
| pT1 (I): Cervical carcinoma confined to uterus (extension to corpus should be disregarded) (TNM category and FIGO stage) (uterine cervix) |
pT1 |
| pT1 (I): Tumour confined to corpus uteri (TNM category and FIGO stage) (corpus uteri) |
pT1 |
| pT1 (I): Tumour confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension (TNM category and FIGO stage) (vulva) |
pT1 |
| pT1 (I): Tumour confined to uterus (TNM category and FIGO stage) (gestational trophoblast) |
pT1 |
| pT1 (I): Tumour confined to vagina (TNM category and FIGO stage) (vagina) |
pT1 |
| pT1 (I): Tumour limited to ovaries (one or both) (TNM category and FIGO stage) (ovary) |
pT1 |
| pT1 (I): Tumour limited to the fallopian tube(s) (TNM category and FIGO stage) (fallopian tube) |
pT1 |
| pT1 category |
pT1 |
| pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (melanoma of the skin) |
pT1 |
| pT1: Solitary tumor without vascular invasion (liver, including intrahepatic bile ducts) |
pT1 |
| pT1: Tumour 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) (ciliary body and choroid) (uveal melanoma) |
pT1 |
| pT1: Tumour 2 cm or less in greatest dimension (anal canal) |
pT1 |
| pT1: Tumor 2 cm or less in greatest dimension (breast) |
pT1 |
| pT1: Tumour 2 cm or less in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT1 |
| pT1: Tumour 2 cm or less in greatest dimension |
pT1 |
| pT1: Tumour 2 cm or less in greatest dimension (lip and oral cavity) |
pT1 |
| pT1: Tumour 2 cm or less in greatest dimension (oropharynx) |
pT1 |
| pT1: Tumour 2 cm or less in greatest dimension limited to the thyroid (thyroid) |
pT1 |
| pT1: Tumour 2 cm or less in greatest dimension without extraparenchymal extension (major salivary glands) |
pT1 |
| pT1: Tumour 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus) (lung) |
pT1 |
| pT1: Tumour 5 cm or less in greatest dimension (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT1 |
| pT1: Tumour 7 cm or less in greatest dimension, limited to the kidney (kidney) |
pT1 |
| pT1: Tumour 8 cm or less in greatest dimension (bone) |
pT1 |
| pT1: Tumour 8 cm or less in greatest dimension (osseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT1 |
| pT1: Tumour confined to the bile duct histologically (extrahepatic bile ducts) |
pT1 |
| pT1: Tumour confined to the nasopharynx (nasopharynx) |
pT1 |
| pT1: Tumour confined to the retina, vitreous, or subretinal space. No optic nerve or choroidal invasion (retinoblastoma) |
pT1 |
| pT1: Tumour invades lamina propria or muscle layer (gallbladder) |
pT1 |
| pT1: Tumour invades lamina propria or submucosa (oesophagus) |
pT1 |
| pT1: Tumour invades lamina propria or submucosa (small intestine) |
pT1 |
| pT1: Tumour invades lamina propria or submucosa (stomach) |
pT1 |
| pT1: Tumour invades subepithelial connective tissue (urinary bladder, ureter, renal pelvis) |
pT1 |
| pT1: Tumour invades submucosa (appendix) |
pT1 |
| pT1: Tumour invades submucosa (colon/rectum) |
pT1 |
| pT1: Tumour involves ipsilateral parietal pleura, with or without focal involvement of visceral pleura (thoracic mesothelioma) |
pT1 |
| pT1: Tumour limited to ampulla of Vater or sphincter of Oddi (ampulla of Vater) |
pT1 |
| pT1: Tumour limited to one subsite of hypopharynx and 2 cm or less in greatest dimension (hypopharynx) |
pT1 |
| pT1: Tumour limited to one subsite of supraglottis with normal vocal cord mobility (larynx, supraglottis) |
pT1 |
| pT1: Tumour limited to the iris (iris) (uveal melanoma) |
pT1 |
| pT1: Tumour limited to the maxillary sinus mucosa with no erosion or destruction of bone (maxillary sinus) |
pT1 |
| pT1: Tumour limited to the pancreas, 2 cm or less in greatest dimension (exocrine pancreas) |
pT1 |
| pT1: Tumour limited to the subglottis (larynx, subglottis) |
pT1 |
| pT1: Tumour limited to the testis and epididymis without vascular/lymphatic invasion; tumour may invade into the tunica albuginea but not the tunica vaginalis (testis) |
pT1 |
| pT1: Tumour limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) |
pT1 |
| pT1: Tumor restricted to any one subsite, with or without bony invasion (nasal cavity and ethmoid sinus) |
pT1 |
| pT1a (IA): Invasive carcinoma diagnosed only by microscopy. All macroscopically visible lesions (even with superficial invasion) are pT1b/IB (TNM category and FIGO stage) (uterine cervix) |
pT1a |
| pT1a (IA): Tumour confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm (TNM category and FIGO stage) (vulva) |
pT1a |
| pT1a (IA): Tumour limited to endometrium (TNM category and FIGO stage) (corpus uteri) |
pT1a |
| pT1a (IA): Tumour limited to one fallopian tube, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) |
pT1a |
| pT1a (IA): Tumour limited to one ovary; capsule intact, no tumour on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) |
pT1a |
| pT1a category |
pT1a |
| pT1a1 (IA1): Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread (TNM category and FIGO stage) (uterine cervix) |
pT1a1 |
| pT1a1 category |
pT1a1 |
| pT1a2 (IA2): Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth and 7.0 mm or less horizontal spread (TNM category and FIGO stage) (uterine cervix) |
pT1a2 |
| pT1a2 category |
pT1a2 |
| pT1a: Melanoma 1.0 mm or less in thickness and level II or III, no ulceration (melanoma of the skin) |
pT1a |
| pT1a: Tumour 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) |
pT1a |
| pT1a: Tumour 2 cm or less in greatest dimension, limited to dermis or 2 mm or less in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) |
pT1a |
| pT1a: Tumour 4 cm or less in greatest dimension, limited to the kidney (kidney) |
pT1a |
| pT1a: Tumour 5 cm or less in greatest dimension, superficial tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma) |
pT1a |
FHIR